Literature DB >> 15806488

Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.

Lee A Hebert, Brad H Rovin, Anil K Agarwal, Dan N Spetie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15806488     DOI： 10.1053/j.ajkd.2005.01.033

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  1 in total

1.  Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.

Authors:  Chadwick E Barnes; William A Wilmer; Raul A Hernandez; Christopher Valentine; Leena S Hiremath; Tibor Nadasdy; Anjali A Satoskar; Rose L Shim; Brad H Rovin; Lee A Hebert
Journal:  Nephron Clin Pract       Date:  2011-07-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.